You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Investigational Drug Information for SHR0302


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug SHR0302?

SHR0302 is an investigational drug.

There have been 24 clinical trials for SHR0302. The most recent clinical trial was a Phase 2 trial, which was initiated on April 30th 2021.

The most common disease conditions in clinical trials are Arthritis, Arthritis, Rheumatoid, and Eczema. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Reistone Biopharma Company Limited, and Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine.

There is one US patent protecting this investigational drug and twenty-seven international patents.

Recent Clinical Trials for SHR0302
TitleSponsorPhase
To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative BioavailabilityJiangsu HengRui Medicine Co., Ltd.Phase 1
Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell LymphomaHenan Cancer HospitalPhase 1
Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy SubjectsJiangsu HengRui Medicine Co., Ltd.Phase 1

See all SHR0302 clinical trials

Clinical Trial Summary for SHR0302

Top disease conditions for SHR0302
Top clinical trial sponsors for SHR0302

See all SHR0302 clinical trials

US Patents for SHR0302

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SHR0302 ⤷  Try a Trial Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof Jiangsu Hengrui Medicine Co., Ltd. (Lianyungang, Jiangsu, CN) Shanghai Hengrui Pharmaceutical Co., Ltd. (Shanghai, CN) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for SHR0302

Drugname Country Document Number Estimated Expiration Related US Patent
SHR0302 Australia AU2012357296 2031-12-21 ⤷  Try a Trial
SHR0302 Brazil BR112014014325 2031-12-21 ⤷  Try a Trial
SHR0302 Canada CA2857977 2031-12-21 ⤷  Try a Trial
SHR0302 China CN103415520 2031-12-21 ⤷  Try a Trial
SHR0302 Cyprus CY1121161 2031-12-21 ⤷  Try a Trial
SHR0302 Denmark DK2796460 2031-12-21 ⤷  Try a Trial
SHR0302 European Patent Office EP2796460 2031-12-21 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.